Skip to main content
. 2017 Mar 17;8(30):50155–50163. doi: 10.18632/oncotarget.16334

Table 2. Toxicity observed during therapy.

Toxicity Grade1 (N. %) Grade 2 (N. %) Grade 3 (N. %) Grade 4 (N. %)
Hematological toxicity
Anemia
Leukocytopenia
Thrombocytopenia
17 (25.7%)
20(30.3%)
14(21.2%)
7(10.6%)
12(18.2%)
6(9.1%)
1(1.5%)
6(9.1%)
2(3.0%)
0
5(7.6%)
0
Non-hematological toxicity
Nausea
Vomiting
Diarrhea
Hepatic dysfunction
32(48.5%)
22(33.3%)
2(3.0%)
2(3.0%)
4(6.1%)
5(7.6%)
0
1(1.5%)
0
2(3.0%)
0
0
0
0
0
0
Pancreatitis 1(1.5%)
Skin test positive/Allergy 30(45.5%)
Radiation-related mucositis
Radiation-related dermatitis
18(27.3%)
20(30.3%)
37(56.1%)
34(51.5%)
4(6.1%)
1(1.5%)
0
0